Immunocore Holdings plc (IMCR)
$27.82-4.20%Close
SELLBEAR · day 26
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.4B
- Beta
- 0.82
- P/E (TTM)
- -154.30
- Short % float
- 15.70%
- Days to cover
- 20.7
- SI change
- +1.7%
- 1W
- -5.85%
- 1M
- -14.29%
- vs SPY 1W
- -5.72%
- vs SPY 1M
- -16.80%
Industry peers
FMP comparable companies · ranked by market cap
- BNTXSELLBioNTech SE$24.1BCRISISQ 35$95.84-7.13%
- IBRXBUYImmunityBio, Inc.$10.6BRECOVERYQ 8$10.12-3.16%
- RCUSSELLArcus Biosciences, Inc.$3.1BCRISISQ 17$24.34-7.52%
- XNCRSELLXencor, Inc.$1.9BRECOVERYQ 15$25.04-6.07%
- JANXBUYJanux Therapeutics, Inc.$1.1BRECOVERYQ 11$18.15-5.34%
- IMTXSELLImmatics N.V.$967MCRISISQ 5$7.21-5.27%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IMCR?
- LOPJLB’s latest quantitative signal on Immunocore Holdings plc (IMCR) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is IMCR in?
- Immunocore Holdings plc (IMCR) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Immunocore Holdings plc (IMCR) do?
- Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treat…